Long-term Follow-up of Patients with Relapsed or Refractory Non–Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human StudyMatthew S. Davids, John F. Seymour, Andrew W. Roberts et al.|Clinical Cancer Research|2021Cited by 69